Uli Bialucha
Chief Tech/Sci/R&D Officer bij XILIO THERAPEUTICS, INC.
Profiel
Uli Bialucha is currently the Chief Scientific Officer at Xilio Therapeutics, Inc. Previously, Uli held the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc. Uli completed their undergraduate degree at the University of Sussex and obtained a doctorate from University College London.
Actieve functies van Uli Bialucha
| Bedrijven | Functie | Begin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-04-2021 |
Eerdere bekende functies van Uli Bialucha
| Bedrijven | Functie | Einde |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Uli Bialucha
| University of Sussex | Undergraduate Degree |
| University College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
